Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (HepG2)

Molecular and Cellular Biochemistry

Volumn 233, Issue 1-2, 2002, Pages 153-158

  Man, Ricky Y K ^a   Lynn, Edward G ^a   Cheung, Filly ^a   Tsang, Patricia S Y ^a   O, Karmin ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cholesterol; HMG CoA reductase; Monascus purpureus; Red yeast rice; Statin

Indexed keywords

ANTIBIOTIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; CHOLESTEROL DERIVATIVE; CHOLESTEROL ESTER; CHOLESTIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; NEOMYCIN; PENICILLIN G; STREPTOMYCIN;

ARTICLE; ATHEROSCLEROSIS; CANCER CELL CULTURE; CARDIOVASCULAR RISK; CHOLESTEROL SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FERMENTATION TECHNIQUE; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LIPID METABOLISM; NONHUMAN; RICE; YEAST;

MONASCUS; MONASCUS PURPUREUS;

EID: 0036308901     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017487815091     Document Type: Article

References (28)

1. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
4. Lovastatin and simvastatin -inhibitors of HMG CoA reductase and cholesterol biosynthesis
5. Lipoprotein metabolism
6. Intracellular cholesterol transport
7. Nonparametrics: Statistical Methods Based on Ranks
8. Treating hyperlipidemia for the primary prevention of coronary disease. Are higher dosages of lovastatin cost-effective?
9. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement
10. Chinese material medica-vegetable kingdom
11. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells
12. Assay of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase
13. Effects of fasting on phosphatidylcholine biosynthesis in hamster liver: Regulation of choline phosphotransferase activity by endogenous argininosuccinate
14. Classification, prevalence, detection, and evaluation
15. The pathogenesis of atherosclerosis: A perspective for the 1990s
16. Mechanism of monocyte recruitment and accumulation
17. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis
18. Atherosclerosis: Basic mechanisms, oxidation, inflammation, and genetics
19. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: Two-year efficacy and safety follow-up
20. Cholesterol deposition in macrophages: Foam cell formation mediated by cholesterol-enriched oxidized low density lipoprotein
21. Dietary supplement or drug? The case of Cholestin
22. Lovastatin (Mevinolin) in the treatment of heterozygous familial hypercholesterolemia: A multicenter study
23. Regulation of cholesterol metabolism by dietary plant sterols
24. Comparable efficacy of hydrogenated vs. non-hydrogenated plant sterol esters on circulating cholesterol levels in humans
25. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylgiutaryl-coenzyme A reductase
26. Transcriptional modulators affect in vivo protein binding to the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase promoters
27. Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells
28. Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylgiycerides in HepG2 cells